IEQ Capital’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.12M Sell
7,455
-514
-6% -$55.9K 0.01% 1062
2026
Q1
$736K Hold
7,969
﹤0.01% 1137
2025
Q4
$814K Hold
7,969
﹤0.01% 1120
2025
Q3
$498K Sell
7,969
-1,097
-12% -$59.7K ﹤0.01% 1291
2025
Q2
$472K Sell
9,066
-6,417
-41% -$287K ﹤0.01% 1188
2025
Q1
$660K Buy
+15,483
New +$668K 0.01% 876
2022
Q4
Sell
-9,024
Closed -$486K 848
2022
Q3
$486K Buy
9,024
+679
+8% +$34.9K 0.01% 538
2022
Q2
$337K Buy
+8,345
New +$413K 0.01% 577

Other funds holding GH

IEQ Capital's GH Position: Q2 2026 in Review

IEQ Capital reduced its Guardant Health (GH) stake by 6.4% in Q2 2026, selling an estimated $55.9K and leaving 7,455 shares worth $1.12M. The position accounts for 0.01% of the portfolio, ranked #1062.

IEQ Capital first reported a position in GH in Q2 2022 and has held it in 8 quarters since. 598 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • IEQ Capital held 7,455 shares of Guardant Health worth $1.12M as of Q2 2026.
  • IEQ Capital sold 514 Guardant Health shares in Q2 2026, an estimated $55.9K.
  • Guardant Health made up 0.01% of IEQ Capital's portfolio in Q2 2026, its #1062 holding.
  • IEQ Capital first reported a position in Guardant Health in Q2 2022 and has held it in 8 quarters since.
  • 598 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.